13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
|
Name |
WKN |
Börse |
Kurs |
Datum/Zeit |
Diff. |
Diff. % |
Geld |
Brief |
Erster |
Schluss |
|
SANOFI SA INHABER EO 2 |
920657 |
Xetra |
87,490 |
18.06.24 10:02:35 |
-0,200 |
-0,23% |
87,500 |
87,550 |
87,800 |
87,690 |
|
REGENERON PHARMAC.DL-,001 |
881535 |
Frankfurt |
969,600 |
18.06.24 08:14:43 |
-6,200 |
-0,64% |
968,000 |
979,600 |
969,600 |
975,800 |